Cargando…

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine

Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. We used transcranial magnetic stimulation (TMS) to evaluate changes in cortical excitability and plasticity in patients with chronic migraine (CM) treated with botulinum neurotoxin type A (BoNT/A). We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valente, Mariarosaria, Lettieri, Christian, Russo, Valentina, Janes, Francesco, Gigli, Gian Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229748/ https://www.ncbi.nlm.nih.gov/pubmed/34072379 http://dx.doi.org/10.3390/toxins13060392

Ejemplares similares

Botulinum Toxin Type A for the Treatment of Auriculotemporal Neuralgia—A Case Series
por: Tereshko, Yan, et al.
Publicado: (2023)

Clinical and neurophysiological characterization of muscular weakness in severe COVID-19
por: Bax, Francesco, et al.
Publicado: (2021)

Botulinum toxin type A for genitofemoral neuralgia: A case report
por: Tereshko, Yan, et al.
Publicado: (2023)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
por: Schaefer, Sara M., et al.
Publicado: (2015)

May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study
por: Smeralda, Carmelo Luca, et al.
Publicado: (2020)

Nummular headache: a case report of remission following ketogenic diet and botulinum toxin type A injections
por: Tereshko, Yan, et al.
Publicado: (2023)

The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
por: Tereshko, Yan, et al.
Publicado: (2023)

Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study
por: Pellitteri, Gaia, et al.
Publicado: (2022)

The Effect of Three Different Ketogenic Diet Protocols on Migraine and Fatigue in Chronic and High-Frequency Episodic Migraine: A Pilot Study
por: Tereshko, Yan, et al.
Publicado: (2023)

Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017)

Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia
por: Maezawa, Hitoshi, et al.
Publicado: (2022)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
por: Bono, Francesco, et al.
Publicado: (2023)

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
por: Burstein, Rami, et al.
Publicado: (2014)

Neurologic uses of botulinum neurotoxin type A
por: Ney, John P, et al.
Publicado: (2007)

Botulinum Neurotoxin Type A in Neurology: Update
por: Orsini, Marco, et al.
Publicado: (2015)

Clinical neurophysiology of migraine with aura
por: Coppola, Gianluca, et al.
Publicado: (2019)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination”
por: Vogrig, Alberto, et al.
Publicado: (2022)

2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study
por: Tereshko, Yan, et al.
Publicado: (2023)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

New botulinum neurotoxin constructs for treatment of chronic pain
por: Leese, Charlotte, et al.
Publicado: (2023)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report
por: Tereshko, Yan, et al.
Publicado: (2022)

Comparison of botulinum neurotoxin type A formulations in Asia
por: Frevert, Jürgen, et al.
Publicado: (2018)

Rapid SERS Detection of Botulinum Neurotoxin Type A
por: Subekin, Alexei, et al.
Publicado: (2023)

Action of Botulinum Neurotoxin E Type in Experimental Epilepsies
por: Antonucci, Flavia, et al.
Publicado: (2023)

Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia
por: Yeung, Winnie, et al.
Publicado: (2022)

Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain
por: Go, Eun Jin, et al.
Publicado: (2021)

Neurophysiology of migraine
por: Sandrini, Giorgio, et al.
Publicado: (2001)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iduu6p6id444ln9n8aenfca31m